HealthMore in Health→
Germany’s Planned Healthcare Cuts Draw Early Pushback From Novartis
Key Takeaways
- Germany plans to cut more than €60 billion in healthcare costs.
- Novartis CEO Vas Narasimhan said the company is very disappointed.
- The proposal could affect pharmaceutical sales in a major European market.
DE
DT Editorial Team··via endpoints.news